Lymphoid organ development and inflammation have previously been considered
as distinct mechanistically and functionally. In recent years, it has been
realized that these phenomena have much in common. This insight has been g
ained from the recognition that cytokines of the lymphotoxin (LT)/tumor nec
rosis factor (TNF) family are involved in both processes. The members of th
e family, LT-alpha, LT-beta, and TNF-alpha, and their multiple receptors pa
rticipate combinatorially in lymphoid organ development and chronic inflamm
ation. When inflammation that arises in microbial infection or autoimmune d
isease becomes chronic, it can take on the appearance of organized lymphoid
tissue and has been called a tertiary lymphoid organ. Data with transgenic
and knockout mice suggest that the process is cytokine-mediated and could
be called "lymphoid neo-organogenesis," LT as LT-alpha(3) and LT-alpha(1)be
ta(2) plays a key role in these processes. Data obtained in vitro in an end
othelial cell line and in vivo in transgenic and knockout mice indicate tha
t LT influences these events through induction of adhesion molecules such a
s E-selectin adhesion molecule (ELAM), vascular cell adhesion molecule (VCA
M), intercellular adhesion molecule (ICAM), mucosal addressin cellular adhe
sion molecule (MAdCAM), and peripheral node addressin (PNAd), and chemokine
s.